By capturing and characterizing GPC1 mRNA expression within an exosome‐dominated EV subpopulation (Exo), as well as its membrane protein expression on tumor‐associated microvesicles (tMV), we have unveiled a potential single‐gene, dual‐biomarker strategy for the diagnosis and prognosis of PDAC. Here, GPC1 is linked to neoplasm.